NEW Delhi: India announced Tuesday a partial lifting of a fresh export ban on a malaria drug seen as a potential coronavirus treatment, after US President Donald Trump hinted at "retaliation".
Citing domestic needs, India banned on Saturday exports of hydroxychloroquine which has shown early promise against COVID-19 in small-scale studies in France and China. India is the world’s largest producer and exporter of the drug, according to media reports.
Global stocks are however limited and Trump said that he had pressed Indian Prime Minister Narendra Modi this weekend to expedite shipments, hinting at consequences otherwise. "If he doesn’t allow it to come out, he doesn’t allow it to come out, that would be okay, but of course, there may be retaliation, why wouldn’t there be?" Trump said on Monday.
The corporate logo of the UnitedHealth Group appears on the side of one of their office buildings in Santa Ana,...
A television journalist sets his camera inside the premises of the Supreme Court in New Delhi February 18,...
Supporters of pro-Kurdish Peoples' Equality and Democracy Party display flags with a portrait of jailed Kurdistan...
This picture shows President Vladimir Putin attending a meeting of the Supreme State Council of the Union States of...
Greenlandic Prime Minister Mute B Egede attends a press conference in the Mirror Hall at the Prime Minister's Office,...
Travellers push carts with their luggage at the departure area of Terminal 3 at Indira Gandhi International Airport in...
